Concourse Financial Group Securities, Inc. Abcam PLC Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share
Q3 2023 Oct 30, 2023	BUY	$21.54 - $24.41 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$21.54 - $24.41 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$12.62 - $24.47 $0 - $0
Q1 2023 May 15, 2023	BUY	$12.98 - $17.1 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$13.92 - $17.0 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$13.36 - $16.75 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$12.69 - $19.25 $0 - $0
Q1 2022 May 09, 2022	BUY	$15.5 - $23.89 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$20.04 - $23.84 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$17.38 - $21.54 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$18.47 - $22.11 $0 - $0
Q1 2021 May 13, 2021	BUY	$19.22 - $24.3 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$18.2 - $22.45 $0 - $0

Others Institutions Holding ABCM

# of Institutions

Shares Held

1.03M

Call Options Held

Put Options Held

View Full List

About Abcam plc

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

More about ABCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account